Cover Image

Efficacy and safety of fenofibrate add-on therapy in patients with primary biliary cholangitis refractory to ursodeoxycholic acid: A retrospective study and updated meta-analysis

Background: Ursodeoxycholic acid (UDCA) is currently used for the treatment of primary biliary cholangitis (PBC), but some people do not respond well to UDCA. It reported that the combination of fenofibrate and UDCA can improve the clinical indices in these patients. However, more high-quality evide...

Full description

Saved in:

Bibliographic Details
Main Authors:	Xuan Guoyun (Author), Ding Dawei (Author), Liu Ning (Author), Hu Yinan (Author), Yang Fangfang (Author), Tian Siyuan (Author), Sun Hao (Author), Yang Jiaqi (Author), Xu Ang (Author), Guo Guanya (Author), Chen Xi (Author), Shang Yulong (Author), Han Ying (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-08-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A randomized, controlled trial on fenofibrate in primary biliary cholangitis patients with incomplete response to ursodeoxycholic acid
by: Chunlei Li, et al.
Published: (2022)

Fibrates for the Treatment of Primary Biliary Cholangitis Unresponsive to Ursodeoxycholic Acid: An Exploratory Study
by: Guilherme Grossi Lopes Cançado, et al.
Published: (2022)

Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis
by: Zhang Y, et al.
Published: (2015)

Curative effect of anti-fibrosis Chinese patent medicines combined with ursodeoxycholic acid for primary biliary cholangitis: A systematic review and meta-analysis
by: Yufei Bi, et al.
Published: (2023)

Evaluation of the effects of additional therapy with Berberis vulgaris oxymel in patients with refractory primary sclerosing cholangitis and primary biliary cholangitis: A quasi-experimental study
by: Zahra Naghibi, et al.
Published: (2021)

Fenofibrate in primary sclerosing cholangitis; a randomized, double‐blind, placebo‐controlled trial
by: Behzad Hatami, et al.
Published: (2022)

Antimitochindrial and antinuclear antibodies in primary biliary cholangitis
by: Dana Saipiyeva, et al.
Published: (2019)

Use of Ursodeoxycholic Acid for the Treatment of Biliary Dysfunction in Children
by: T.V. Yaroshevskaya, et al.
Published: (2013)

Experimental Pharmacological Agents for the Treatment of Primary Biliary Cholangitis
by: Floreani A
Published: (2020)

Early cholangitis after portoenterostomy in children with biliary atresia
by: Priya Ramachandran, et al.
Published: (2019)

Quality of Life in Primary Biliary Cholangitis - Advances in the Treatment
by: Agnieszka Kuzio, et al.
Published: (2024)

Experience of using ursodeoxycholic acid in the therapy of biliary sludge in children
by: O.Yu. Belousova, et al.
Published: (2018)

Health related quality of life in patients with primary biliary cholangitis
by: Fahad Abdallah Yassin, et al.
Published: (2022)

Gastric Xanthomatosis Secondary to Lipoprotein X in Primary Biliary Cholangitis
by: Erin Petrie MD, et al.
Published: (2022)

Diffuse xanthomas in a patient with primary biliary cholangitis and lipoprotein X
by: Jasmine Harris, MS, et al.
Published: (2021)

Atypical primary biliary cholangitis results in vanishing bile duct syndrome with cutaneous xanthomas: a case report
by: Yuebo Jia, et al.
Published: (2022)

New developments in the treatment of primary biliary cholangitis – role of obeticholic acid
by: Jhaveri MA, et al.
Published: (2017)

Concurrence of multiple sclerosis and primary biliary cholangitis: A case series study
by: Mokhgan Sattar, et al.
Published: (2020)

ACUTE CHOLANGITIS, COMPLICATED BY BILIARY SEPSIS: CLINICAL CASE WITH A FAVORABLE OUTCOME
by: I. G. Malakhova, et al.
Published: (2016)

Autoimmune hepatitis and primary biliary cholangitis overlap syndrome after COVID-19
by: Marlone Cunha-Silva, et al.
Published: (2023)

EGD for Refractory Toxidromes: Is It Time to Add to the Algorithm?
by: Kelsey Allen MD, et al.
Published: (2022)

Early bile drainage improves native liver survival in biliary atresia without cholangitis
by: Fei Liu, et al.
Published: (2023)

CD19+CD24hiCD38hi B Cell Dysfunction in Primary Biliary Cholangitis
by: Qubo Chen, et al.
Published: (2020)

Endoscopic Extraction of Biliary Fascioliasis Diagnosed Using Intraductal Ultrasonography in a Patient with Acute Cholangitis
by: Ji Su Ha, et al.
Published: (2015)

Transcutaneous Neuromodulation improved inflammation and sympathovagal ratio in patients with primary biliary ssscholangitis and inadequate response to Ursodeoxycholic acid: a pilot study
by: Hui Yang, et al.
Published: (2020)

Add-on Levetiracetam in Children With Refractory Epilepsy: A Systematic Review
by: Ali Abbaskhanian, et al.
Published: (2016)

Add-on Levetiracetam in Children With Refractory Epilepsy: A Systematic Review
by: Ali Abbaskhanian, et al.
Published: (2016)

Characterization of patients with primary biliary cholangitis and autoimmune hepatitis from a community hospital in East Harlem
by: Priyanka Yerragorla, et al.
Published: (2020)

Relationship between pruritus and sleep in participants with primary biliary cholangitis in the Phase 2b GLIMMER trial
by: Robyn von Maltzahn, et al.
Published: (2024)

Clinical course and response to treatment of Cuban patients with primary biliary cholangitis. Institute of Gastroenterology, 2003-2020
by: Deyanira La Rosa Hernández, et al.
Published: (2022)

Efficacy and safety of pharmacological interventions for pruritus in primary biliary cholangitis: A systematic review and meta-analysis
by: Chenyi Xu, et al.
Published: (2022)

Attenuation of the severity and changes in the microbiota in an animal model of primary biliary cholangitis by FOXP3− regulatory T cells
by: Yi‐Lien Chen, et al.
Published: (2023)

Development and adaptation of patient-reported outcome measures for patients who experience itch associated with primary biliary cholangitis
by: Mona L. Martin, et al.
Published: (2019)

Systemic Oxidative Balance Reflects the Liver Disease Progression Status for Primary Biliary Cholangitis (Pbc): The Narcissus Fountain
by: Marcello Dallio, et al.
Published: (2024)

Therapeutic efficacy evaluation of the reference drug ursodeoxycholic acid and its analogues in the biliary sludge dissolution: a meta-analysis
by: Yury A. Kucheryavyy, et al.
Published: (2023)

Characteristics of the Gut Microbiome and IL-13/TGF-β1 Mediated Fibrosis in Post-Kasai Cholangitis of Biliary Atresia
by: Lingdu Meng, et al.
Published: (2021)

Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for Crohn's disease in Polish patients
by: Gaj Pawel, et al.
Published: (2008)

STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY)
by: S. Yu. Martsevich, et al.
Published: (2015)

STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY)
by: S. Yu. Martsevich, et al.
Published: (2015)

Number of cholangitis episodes as a prognostic marker to predict timing of liver transplantation in biliary atresia patients after Kasai portoenterostomy
by: Szu-Ying Chen, et al.
Published: (2018)